1 terminated, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
Follow PND 1186: new trials by email Literature Review of PND 1186 trials Research Report on PND 1186
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies VS-4718 - Non Hematologic Cancers, Metastatic Cancer | Phase 1 | Terminated | Verastem, Inc. | 48 | 2013-06-01 | 2017-07-28 |
| Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia VS-4718 - Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia | Phase 1 | Withdrawn | Verastem, Inc. | 2017-01-27 |
Burkitt Lymphoma (1) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Neoplasm Metastasis (1) · Recurrence (1)
Verastem, Inc. (2)
United States (1)